New Oncology Leader for Synovate

Synovate Healthcare has hired Kris Weinberg, a 16-year veteran of the oncology field, as VP of Longitudinal Oncology Services.

Weinberg worked previously in sales, sales management, reimbursement and product development roles in the start-up commercial team at Genomic Health, Inc., as VP of Sales at IntrinsiQ Data Corporation, and as Director of Managed Care at Impath, Inc. prior to its successful IPO in 1996. He holds a Master of Public Administration degree from Marist College and a BA degree from Siena College. Himself a lymphoma survivor, he also served several years as a board member for the Lymphoma Research Foundation.

Jackie Ilacqua, Synovate's Senior VP and Executive Director, Global Tandem Oncology Monitor, comments: 'This is a really exciting hire for Synovate. Kris' extensive understanding of the field of oncology, in addition to his sales and product development experience, provides the perfect spearhead for our longitudinal oncology data initiatives.'

Synovate Healthcare had a busy November, with the announcement of the expansion of its Hepatitis B and Hepatitis C Global Therapy Monitors (www.mrweb.com/drno/news6138.htm ) and the opening of a new US office for its fieldwork division (www.mrweb.com/drno/news6098.htm ).

The company is online at www.synovate.com/healthcare .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.

• Synovate USA
• All news
• MrWeb info